Arsenic trioxide: an anti cancer missile with multiple warheads.

Yair Gazitt, Cagla Akay

Journal: Hematology (Amsterdam, Netherlands) 2005;10(3):205-13

PMID: 16019469

Abstract

The proven efficacy of ATO in the treatment of APL and the emerging importance of ATO in other diseases prompted extensive studies of the mechanisms of action of ATO in APL and in other types of cancers. In this review we will focus on downstream events in ATO-induced intrinsic and extrinsic apoptotic pathways with an emphasis on the role of pro-apoptotic and anti-apoptotic proteins and the role of p53 in ATO-induced apoptosis including its effect on cell cycle, its anti-mitotic effect and the role of apoptosis inducing factors (AIF) in ATO-induced apoptosis, chromatin condensation and nuclear fragmentation in myeloma cells as a model.

Address: Department of Medicine/Hematology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284, USA. [email protected]

DOI: 10.1080/10245330500067090

Link outs

Free resources

Full Text Sources:

https://www.tandfonline.com/doi/10.1080/1024533050...

Miscellaneous:

https://assays.cancer.gov/CPTAC-951

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-TP53-2

MeSH Terms: Antineoplastic Agents, Apoptosis, Apoptosis Inducing Factor, Arsenic Trioxide, Arsenicals, Chromatin Assembly and Disassembly, DNA Fragmentation, Flavoproteins, Humans, Leukemia, Promyelocytic, Acute, Membrane Proteins, Mitosis, Oxides, Tumor Suppressor Protein p53